- BLUE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
8-K Filing Data
bluebird bio (BLUE) 8-K22 Nov 21If approved, beti-cel will be the first one-time treatment option to address the underlying genetic cause of diseaseFinancial data
Company Profile